APA

Hackl Á., Cseprekál O., Gessner M., Liebau M. C., Habbig S., Ehren R., Müller C., Taylan C., Dötsch J. & Weber L. T. (20161213). Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference?. : Therapeutic drug monitoring.

Chicago

Hackl Ágnes, Cseprekál Orsolya, Gessner Michaela, Liebau Max Christoph, Habbig Sandra, Ehren Rasmus, Müller Carsten, Taylan Christina, Dötsch Jörg and Weber Lutz T. 20161213. Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference?. : Therapeutic drug monitoring.

Harvard

Hackl Á., Cseprekál O., Gessner M., Liebau M. C., Habbig S., Ehren R., Müller C., Taylan C., Dötsch J. and Weber L. T. (20161213). Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference?. : Therapeutic drug monitoring.

MLA

Hackl Ágnes, Cseprekál Orsolya, Gessner Michaela, Liebau Max Christoph, Habbig Sandra, Ehren Rasmus, Müller Carsten, Taylan Christina, Dötsch Jörg and Weber Lutz T. Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference?. : Therapeutic drug monitoring. 20161213.